Author:
Chen Denglin,Xie Derong,Guo Shuangshuang,Yang Qiong,Jiang Zhimin,Bi Zhuofei,Ma Wen
Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. Nieto J, Grossbard ML, Kozuch P. Metastatic pancreatic cancer 2008: is the glass less empty? Oncologist, 2008, 13: 562–576.
2. Yao J, Feng FY, Lin C, et al. The mechanism of resistance to 2′,2′-difluorodeoxyxytidine (gemcitabine) in a pancreatic cancer cell line. Chin J Oncol (Chinese), 2005, 27: 721–726.
3. Nakahira S, Nakamori S, Tsujie M, et al. Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer. Int J Cancer, 2007, 120: 1355–1363.
4. Lu Z, Kleeff J, Shrikhande S, et al. Expression of the multidrug-resistance 1 (mdr1) gene and prognosis in human pancreatic cancer. Pancreas, 2000, 21: 240–247.
5. Messersmith WA, Hidalgo M, Carducci M, et al. Novel targets in solid tumors: MEK inhibitors. Clin Adv Hematol Oncol, 2006, 4: 831–836.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献